Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HalfLYTELY for Bowel Cleansing in Virtual and Conventional Colonoscopy
NCT00164177Phase 4Completed
- Sponsor
- Braintree Laboratories
- Start
- Oct 2004
- Primary completion
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of polyethylene glycol 3350 + bisacodyl in Gastrointestinal cleansing, sponsored by Braintree Laboratories. Primary endpoint: Efficacy of the preparation to produce a degree of fecal matter and residual liquid that would not interfere with VC or CC. Started Oct 2004; status: completed.
02
Drugs
polyethylene glycol 3350 + bisacodyl
03
Conditions
Gastrointestinal cleansing
Beyond the preview
Go deeper on NCT00164177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00164177.